UNLIMITED TURBO BULL - PFIZER INC | Market Closed - Euronext Paris 17:30:01 13/06/2024 BST | ||
| 0.305 EUR | -3.17% |
|
| Current month | -22.78% | ||
| 1 month | -20.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 13/06/24 | 0.305 | -3.17% |
| 12/06/24 | 0.315 | -11.27% |
| 11/06/24 | 0.355 | +2.90% |
| 10/06/24 | 0.345 | -18.82% |
| 07/06/24 | 0.425 | -6.59% |
Real-time Euronext Paris
Last update June 13, 2024 at 05:30 pm
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| 993BS | |
| ISIN | DE000SV1Z5Z8 |
| Date issued | 13/03/2023 |
| Strike | 24.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.63 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.805 € |
|---|---|
| Lowest since issue | 0.095 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.65
USD
Average target price
31.92
USD
Spread / Average Target
+15.43%
- Stock Market
- Certificates
- 993BS Certificat
